{"transactions":[{"id":1749500,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-03T16:49:51.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":437244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":437244,"derivative":{"exercise_price":0.2088,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":437244},"source":{"system":"sec-edgar","filing":"0001493152-23-039339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315223039339/ownership.xml","form_type":"4"}},{"id":2114323,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-11-16T21:33:28.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":142657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":142657,"derivative":{"exercise_price":0.7268,"expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":142657},"source":{"system":"sec-edgar","filing":"0001493152-22-032691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315222032691/ownership.xml","form_type":"4"}},{"id":2453969,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T17:45:54.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":7859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":290472,"source":{"system":"sec-edgar","filing":"0000905718-22-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571822000007/ownership.xml","form_type":"4"}},{"id":2528409,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-02T16:21:20.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":90882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":90882,"derivative":{"exercise_price":1.12,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":90882},"source":{"system":"sec-edgar","filing":"0001493152-21-026991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315221026991/ownership.xml","form_type":"4"}},{"id":2554130,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T18:03:43.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2021, the Reporting Person was issued 6,106 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":282613,"source":{"system":"sec-edgar","filing":"0001493152-21-024397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315221024397/ownership.xml","form_type":"4"}},{"id":2647337,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T17:30:19.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":10244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2021, the Reporting Person was issued 10,244 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":276507,"source":{"system":"sec-edgar","filing":"0001493152-21-015878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315221015878/ownership.xml","form_type":"4"}},{"id":2655694,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T17:42:15.000Z","date":"2021-06-19","kind":"exercise","acquired":false,"shares":6,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905718-21-000826","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571821000826/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655693,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:42:15.000Z","date":"2021-06-19","kind":"exercise","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":266263,"source":{"system":"sec-edgar","filing":"0000905718-21-000826","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571821000826/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655692,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:42:15.000Z","date":"2021-06-19","kind":"other","acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":254263,"source":{"system":"sec-edgar","filing":"0000905718-21-000826","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571821000826/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2757267,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T19:25:29.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":7560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2021, the Reporting Person was issued 7,560 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":251863,"source":{"system":"sec-edgar","filing":"0000905718-21-000556","document":"wikler_fm4mar312021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571821000556/wikler_fm4mar312021.xml","form_type":"4"}},{"id":2925243,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T18:30:09.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":11673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2020, the Reporting Person was issued 11,673 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":244303,"source":{"system":"sec-edgar","filing":"0001493152-21-000131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315221000131/ownership.xml","form_type":"4"}},{"id":2986227,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-11-10T16:05:37.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":122605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":122605,"derivative":{"exercise_price":0.82,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":122605},"source":{"system":"sec-edgar","filing":"0001493152-20-020923","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220020923/ownership.xml","form_type":"4"}},{"id":3011537,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T16:05:10.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":20725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2020, the Reporting Person was issued 20,725 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":232630,"source":{"system":"sec-edgar","filing":"0001493152-20-019017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220019017/ownership.xml","form_type":"4"}},{"id":3091177,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:45:10.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":20537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2020, the Reporting Person was issued 20,537 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":211905,"source":{"system":"sec-edgar","filing":"0001493152-20-012586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220012586/ownership.xml","form_type":"4"}},{"id":3100716,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-24T21:00:23.000Z","date":"2020-06-23","kind":"other","acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":191368,"source":{"system":"sec-edgar","filing":"0001493152-20-011762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220011762/ownership.xml","form_type":"4"}},{"id":3186017,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T16:10:22.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":26450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2020, the Reporting Person was issued 26,450 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":189568,"source":{"system":"sec-edgar","filing":"0001493152-20-005693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220005693/ownership.xml","form_type":"4"}},{"id":3322161,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-01-03T16:05:38.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":6994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2019, the Reporting Person was issued 6,994 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Incentive Plan. Such shares vest immediately upon grant."}],"balance_after":163118,"source":{"system":"sec-edgar","filing":"0001493152-20-000117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315220000117/ownership.xml","form_type":"4"}},{"id":3379980,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-11-05T16:05:13.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":107416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":107416,"derivative":{"exercise_price":0.912,"expiration_date":"2029-11-01","underlying":"Common Stock","underlying_shares":107416},"source":{"system":"sec-edgar","filing":"0001493152-19-016454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315219016454/ownership.xml","form_type":"4"}},{"id":3400599,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T18:12:41.000Z","date":"2019-06-21","kind":"other","acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock"}],"balance_after":156124,"source":{"system":"sec-edgar","filing":"0001493152-19-014914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315219014914/ownership.xml","form_type":"4"}},{"id":3400598,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-10-02T18:12:41.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":25179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2019, the Reporting Person was issued 25,179 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":154924,"source":{"system":"sec-edgar","filing":"0001493152-19-014914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315219014914/ownership.xml","form_type":"4"}},{"id":3470698,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T18:40:11.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":18524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2019, the Reporting Person was issued 18,524 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":129745,"source":{"system":"sec-edgar","filing":"0001493152-19-010198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000149315219010198/ownership.xml","form_type":"4"}},{"id":3564138,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T16:49:41.000Z","date":"2019-03-31","kind":"grant","acquired":true,"shares":14565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2019, the Reporting Person was issued 14,565 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":111221,"source":{"system":"sec-edgar","filing":"0000905718-19-000329","document":"matinasbio_fm4mar312019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571819000329/matinasbio_fm4mar312019.xml","form_type":"4"}},{"id":3703441,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T16:00:52.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":26681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2018, the Reporting Person was issued 26,681 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":96656,"source":{"system":"sec-edgar","filing":"0000905718-19-000018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571819000018/ownership.xml","form_type":"4"}},{"id":3773930,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T08:16:11.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":128299,"derivative":{"exercise_price":0.74,"exercise_date":"2018-11-01","expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000906","document":"matinasbiofm4_oct12018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000906/matinasbiofm4_oct12018.xml","form_type":"4"}},{"id":3773929,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-11-05T08:16:11.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":128299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":128299,"derivative":{"exercise_price":0.74,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":128299},"source":{"system":"sec-edgar","filing":"0000905718-18-000906","document":"matinasbiofm4_oct12018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000906/matinasbiofm4_oct12018.xml","form_type":"4"}},{"id":3798197,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T16:36:47.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":19294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 1, 2018, the Reporting Person was granted 19,294 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant."}],"balance_after":69975,"source":{"system":"sec-edgar","filing":"0000905718-18-000823","document":"matinasbiofm4_oct12018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000823/matinasbiofm4_oct12018.xml","form_type":"4"}},{"id":3845986,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-08-13T16:00:21.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 36 months commencing on February 2, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":150000,"derivative":{"exercise_price":1.24,"expiration_date":"2028-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000905718-18-000731","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000731/ownership.xml","form_type":"4/A","original_submission_date":"2018-01-05"}},{"id":3869168,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-11T16:28:07.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":32259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 32,259 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 29, 2018, the Reporting Person was granted 32,259 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan.  Such shares vest immediately upon grant."}],"balance_after":50681,"source":{"system":"sec-edgar","filing":"0000905718-18-000622","document":"wikler-matinasfm4_jun292018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000622/wikler-matinasfm4_jun292018.xml","form_type":"4"}},{"id":3884785,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-22T16:33:08.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":6,"price":1000,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased six shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased six shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":6,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905718-18-000586","document":"wikler-matinasfm4_jun212018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000586/wikler-matinasfm4_jun212018.xml","form_type":"4"}},{"id":3949581,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-02T17:10:00.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months."}],"balance_after":100000,"derivative":{"exercise_price":0.44,"expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-18-000450","document":"wiklerfm4_apr302018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000450/wiklerfm4_apr302018.xml","form_type":"4"}},{"id":3976126,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T17:15:29.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":18422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2018, the Reporting Person was issued 18,422 shares of common stock par value $.0001 per share which vest immediately upon grant."}],"balance_after":18422,"source":{"system":"sec-edgar","filing":"0000905718-18-000363","document":"wiklermatinasfm4_mar302018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000363/wiklermatinasfm4_mar302018.xml","form_type":"4"}},{"id":4105241,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":108595,"kind":"person","name":"WIKLER MATTHEW","position":1,"cik":"0001195414","reported_name":"WIKLER MATTHEW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-01-05T17:35:24.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 36 months commencing on February 2, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":150000,"derivative":{"exercise_price":1.24,"expiration_date":"2018-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000905718-18-000033","document":"wiklermatinasfm4_jan22018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1195414/000090571818000033/wiklermatinasfm4_jan22018.xml","form_type":"4"}}]}